Evidence map›Paper›PMID 30987892›Full record

ArticleBioorganic & medicinal chemistry letters2019

A cross-linking approach to map small molecule-RNA binding sites in cells.

Sai Pradeep Velagapudi, Yue Li, Matthew D Disney

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Synthesis of electrophile-tethered preQBeilstein journal of organic chemistry · 2025
    Article
  14. Review
  15. Article
  16. Selective Arylation of RNA 2'-OH Groups via SAngewandte Chemie (International ed. in English) · 2024
    Article
  17. Heterobifunctional small molecules to modulate RNA function.Trends in pharmacological sciences · 2024
    Review
  18. Small molecule approaches to targeting RNA.Nature reviews. Chemistry · 2024
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sai Pradeep VelagapudiDepartment of Chemistry, The Scripps Research Institute, Jupiter, FL 33458, USA.
Yue LiDepartment of Chemistry, The Scripps Research Institute, Jupiter, FL 33458, USA.
Matthew D DisneyDepartment of Chemistry, The Scripps Research Institute, Jupiter, FL 33458, USA. Electronic address: Disney@scripps.edu.

Funding

Sequence-based Design of Small Molecules Targeting RNAR01GM097455 · NIGMS · SCRIPPS FLORIDA · PI DISNEY, MATTHEW D · 2012 to 2019
$4.6M
NIGMS NIH HHS R01 GM097455
6 · The paper itself

Abstract

Methods to identify RNAs bound by small molecules in cells are sparse. Herein, an advance to identify the direct RNA targets of small molecules in cells is described. The approach, dubbed Chemical Cross-Linking and Isolation by Pull-down to Map Small Molecule-RNA Binding Sites (Chem-CLIP-Map-Seq), appends a cross-linker and a purification tag onto a small molecule. In cells, the compound binds to RNA and undergoes a proximity-based reaction. The cross-linked RNA is purified and then amplified using a universal reverse transcription (RT) primer and gene-specific PCR primers. At nucleotides proximal to the binding site, RT "stops" are observed. This approach has broad utility in identifying and validating the RNA targets and binding sites of small molecules in the context of a complex cellular system.

Indexed as

Binding SitesCross-Linking ReagentsHumansSmall Molecule LibrariesCross-Linking ReagentsSmall Molecule LibrariesOncogenic microRNARNASmall moleculesTarget profilingTarget validation

Identifiers

PMID30987892
PMCPMC6598432

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.